The role of lipids in Parkinson's disease

H Xicoy, B Wieringa, GJM Martens - Cells, 2019 - mdpi.com
Parkinson's disease (PD) is a neurodegenerative disease characterized by a progressive
loss of dopaminergic neurons from the nigrostriatal pathway, formation of Lewy bodies, and …

Discovery of soluble epoxide hydrolase inhibitors from chemical synthesis and natural products

CP Sun, XY Zhang, C Morisseau… - Journal of medicinal …, 2020 - ACS Publications
Soluble epoxide hydrolase (sEH) is an α/β hydrolase fold protein and widely distributed in
numerous organs including the liver, kidney, and brain. The inhibition of sEH can effectively …

Soluble epoxide hydrolase as a therapeutic target for neuropsychiatric disorders

J Shan, K Hashimoto - International journal of molecular sciences, 2022 - mdpi.com
It has been found that soluble epoxide hydrolase (sEH; encoded by the EPHX2 gene) in the
metabolism of polyunsaturated fatty acids (PUFAs) plays a key role in inflammation, which …

Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression

A Fishbein, W Wang, H Yang, J Yang… - Proceedings of the …, 2020 - National Acad Sciences
Toxic environmental carcinogens promote cancer via genotoxic and nongenotoxic
pathways, but nongenetic mechanisms remain poorly characterized. Carcinogen-induced …

Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade

A Sala, E Proschak, D Steinhilber, GE Rovati - Biochemical Pharmacology, 2018 - Elsevier
Chronic inflammation and pain is a major global health problem, and nonsteroidal anti-
inflammatory drugs (NSAIDs) remain the most frequently prescribed drugs and common …

Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases

C Navarro-Mabarak, R Camacho-Carranza… - Drug metabolism …, 2018 - Taylor & Francis
Cytochromes P450 (CYPs) constitute a family of enzymes that can be found in the
endoplasmic reticulum (ER), mitochondria or the cell surface of the cells. CYPs are …

Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders

S Zarriello, JP Tuazon, S Corey, S Schimmel… - Progress in …, 2019 - Elsevier
Soluble epoxide hydrolase (sEH) degrades epoxides of fatty acids including
epoxyeicosatrienoic acid isomers (EETs), which are produced as metabolites of the …

Soluble epoxide hydrolase inhibition to face neuroinflammation in Parkinson's disease: A new therapeutic strategy

M Pallàs, S Vázquez, C Sanfeliu, C Galdeano… - Biomolecules, 2020 - mdpi.com
Neuroinflammation is a crucial process associated with the pathogenesis of
neurodegenerative diseases, including Parkinson's disease (PD). Several pieces of …

Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity

K Hiesinger, KM Wagner, BD Hammock… - Prostaglandins & other …, 2019 - Elsevier
Over the last two decades polypharmacology has emerged as a new paradigm in drug
discovery, even though developing drugs with high potency and selectivity toward a single …

Alterations of cytochrome P450s and UDP-glucuronosyltransferases in brain under diseases and their clinical significances

Y Sheng, H Yang, T Wu, L Zhu, L Liu… - Frontiers in …, 2021 - frontiersin.org
Cytochrome P450s (CYPs) and UDP-glucuronosyltransferases (UGTs) are both greatly
important metabolic enzymes in various tissues, including brain. Although expressions of …